Effect of LIXIsenatide on the Renal System

NCT02276196 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Kidney Disease
Diabetic Nephropathy
Diabetes Mellitus
Glucagon-Like Peptide 1

Interventions

DRUG: Lixisenatide
DRUG: Insulin glulisine

Sponsor

Amsterdam UMC, location VUmc